This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prognosis

Authoring team

PCP occurring in a patient is an indicator of something going seriously wrong elsewhere.

A poor prognosis is anticipated by the administration of prophylactic antibiotics (co-trimoxazole and inhaled pentamidine) to people with known HIV infection as their CD4 positive count falls below 200.

Overall in-hospital mortality rates are 15% for HIV-infected patients and 50% in some HIV-uninfected patients (1) but one 17-year retrospective study found in-hospital mortality rates of 25.4%, increasing to 58% if ICU admission was required. (2)

References

  1. Cilloniz C, Dominedo C, Alvarez-Martinez MJ, et al; Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients. Expert Rev Anti Infect Ther. 2019 Oct;17(10):787-801
  2. Schmidt JJ, Lueck C, Ziesing S, et al. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care. 2018 Nov 19;22(1):307

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.